The efficacy of rhBMP-2 for posterolateral lumbar fusion in smokers

scientific article published on July 2007

The efficacy of rhBMP-2 for posterolateral lumbar fusion in smokers is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/BRS.0B013E318074C366
P698PubMed publication ID17621221

P2093author name stringLeah Y Carreon
Steven D Glassman
Scott D Boden
John R Dimar
James W Hardacker
Kenneth Burkus
Philip W Pryor
P433issue15
P407language of work or nameEnglishQ1860
P304page(s)1693-1698
P577publication date2007-07-01
P1433published inSpineQ7577526
P1476titleThe efficacy of rhBMP-2 for posterolateral lumbar fusion in smokers
P478volume32

Reverse relations

cites work (P2860)
Q371094772011 AOA Symposium: Tissue Engineering and Tissue Regeneration: AOA critical issues
Q38726586A Review of the Clinical Side Effects of Bone Morphogenetic Protein-2.
Q28606708A consensus statement regarding the utilization of BMP in spine surgery
Q28606711A review of the current published spinal literature regarding bone morphogenetic protein-2: an insight into potential bias
Q36804962Anxiety and Depression in Bidirectional Relations Between Pain and Smoking: Implications for Smoking Cessation
Q37146795Associations between chronic pain status, attempts to quit smoking, and use of pharmacotherapy for smoking cessation
Q92803134BMP and Beyond: A 25-Year Historical Review of Translational Spine Research at Emory University
Q49992607Bone graft materials for posterolateral fusion made simple: a systematic review
Q39026571Bone substitutes and expanders in Spine Surgery: A review of their fusion efficacies
Q100431264Characteristics of Reported Industry Payments to Neurosurgeons: A 5-Year Open Payments Database Study
Q28084738Clinical translation of controlled protein delivery systems for tissue engineering
Q42235497Combination of bone marrow mesenchymal stem cells sheet and platelet rich plasma for posterolateral lumbar fusion
Q36197038Comparison of rhBMP-2 versus Autogenous Iliac Crest Bone Graft for 2-Level Anterior Cervical Discectomy and Fusion for Cervical Spondylotic Myelopathy
Q37811502Evaluation and Treatment of Spinal Injuries in the Obese Patient
Q37759995Formation of painful seroma and edema after the use of recombinant human bone morphogenetic protein-2 in posterolateral lumbar spine fusions
Q33639409Formulation, Delivery and Stability of Bone Morphogenetic Proteins for Effective Bone Regeneration.
Q64335272Incidence of Osteoporosis-Related Complications Following Posterior Lumbar Fusion
Q28606705Lessons from the infuse trials: do we need a classification of bias in scientific publications and editorials?
Q30277865Long-Segment Fusion for Adult Spinal Deformity Correction Using Low-Dose Recombinant Human Bone Morphogenetic Protein-2: A Retrospective Review of Fusion Rates
Q36460730Negative effects of smoking, workers' compensation, and litigation on pain/disability scores for spine patients
Q28681258Reporting of industry funded study outcome data: comparison of confidential and published data on the safety and effectiveness of rhBMP-2 for spinal fusion
Q30449937Spinal reconstruction and bone morphogenetic proteins: open questions.
Q41930739Successful spinal fusion by E. coli-derived BMP-2-adsorbed porous beta-TCP granules: a pilot study
Q40531898The Effect of Smoking Status on Successful Arthrodesis After Lumbar Instrumentation Supplemented with rhBMP-2.
Q49238446The Effect of Smoking on Spinal Fusion
Q28650307The controversy surrounding bone morphogenetic proteins in the spine: a review of current research
Q37429386The effects of smoking on intersegmental motion in the upper thoracic spine
Q33972090The use of RhBMP-2 in single-level transforaminal lumbar interbody fusion: a clinical and radiographic analysis
Q34886122Transforaminal lumbar interbody fusion rates in patients using a novel titanium implant and demineralized cancellous allograft bone sponge
Q28564040Use of OP-1 (rhBMP-7) in posterolateral lumbar arthrodesis
Q38624760Use of recombinant human bone morphogenetic protein-2 in spine surgery

Search more.